SUNRISE-DI study. The daily sunrise is easier to predict than the benefit of adjuvant treatment in colon cancer

dc.contributor.author	Carmona-Bayonas, Alberto
dc.contributor.author	Valentí, V
dc.contributor.author	Jiménez-Fonseca, Paula
dc.contributor.author	Salazar, R
dc.date.accessioned	2025-05-06T10:41:41Z
dc.date.available	2025-05-06T10:41:41Z
dc.date.issued	2021
dc.identifier.citation	Carmona-Bayonas A, Valentí V, Jiménez-Fonseca P, Salazar R. SUNRISE-DI study. The daily sunrise is easier to predict than the benefit of adjuvant treatment in colon cancer. ESMO Open. agosto de 2021;6(4):100205.
dc.identifier.uri	https://sms.carm.es/ricsmur/handle/123456789/18828
dc.language.iso	eng
dc.publisher	Elsevier B.V.
dc.rights	Atribución-NoComercial-SinDerivadas 4.0 España
dc.rights.uri	https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es	*
dc.subject.mesh	Adjuvants, Pharmaceutic
dc.subject.mesh	Colonic Neoplasms/drug therapy
dc.subject.mesh	Humans
dc.title	SUNRISE-DI study. The daily sunrise is easier to predict than the benefit of adjuvant treatment in colon cancer
dc.type	info:eu-repo/semantics/article
dc.identifier.pmid	34242967
dc.relation.publisherversion	https://dx.doi.org/10.1016/j.esmoop.2021.100205
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.identifier.doi	10.1016/j.esmoop.2021.100205
dc.journal.title	ESMO Open
dc.identifier.essn	2059-7029